Skip to main content
Journal cover image

The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial.

Publication ,  Journal Article
Blumenthal, JA; Babyak, MA; Craighead, WE; Davidson, J; Hinderliter, A; Hoffman, B; Doraiswamy, PM; Sherwood, A
Published in: Depress Anxiety
February 2021

OBJECTIVES: To explore the anxiolytic effects of a 4-month randomized, placebo-controlled trial of exercise and antidepressant medication in patients with major depressive disorder (MDD), and to examine the potential modifying effects of anxiety in treating depressive symptoms. MATERIALS AND METHODS: In this secondary analysis of the SMILE-II trial, 148 sedentary adults with MDD were randomized to: (a) supervised exercise, (b) home-based exercise, (c) sertraline, or (d) placebo control. Symptoms of state anxiety measured by the Spielberger Anxiety Inventory were examined before and after 4 months of treatment. Depressive symptoms were assessed by the Hamilton Depression Rating Scale (HAMD) and Beck Depression Inventory-II (BDI-II). Analyses were carried out using general linear models. RESULTS: Compared to placebo controls, the exercise and sertraline groups had lower state anxiety scores (standardized difference = 0.3 [95% CI = -0.6, -0.04]; p = 0.02) after treatment. Higher pretreatment state anxiety was associated with poorer depression outcomes in the active treatments compared to placebo controls for both the HAMD (p = .004) and BDI-II (p = .02). CONCLUSION: Aerobic exercise as well as sertraline reduced symptoms of state anxiety in patients with MDD. Higher levels of pretreatment anxiety attenuated the effects of the interventions on depressive symptoms, however, especially among exercisers. Patients with MDD with higher comorbid state anxiety appear to be less likely to benefit from exercise interventions in reducing depression and thus may require supplemental treatment with special attention to anxiety.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Depress Anxiety

DOI

EISSN

1520-6394

Publication Date

February 2021

Volume

38

Issue

2

Start / End Page

124 / 133

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sertraline
  • Psychiatry
  • Humans
  • Exercise
  • Depressive Disorder, Major
  • Depression
  • Anxiety
  • Adult
  • 5205 Social and personality psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blumenthal, J. A., Babyak, M. A., Craighead, W. E., Davidson, J., Hinderliter, A., Hoffman, B., … Sherwood, A. (2021). The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial. Depress Anxiety, 38(2), 124–133. https://doi.org/10.1002/da.23088
Blumenthal, James A., Michael A. Babyak, Wade Edward Craighead, Jonathan Davidson, Alan Hinderliter, Benson Hoffman, Pudugramam Murali Doraiswamy, and Andrew Sherwood. “The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial.Depress Anxiety 38, no. 2 (February 2021): 124–33. https://doi.org/10.1002/da.23088.
Blumenthal JA, Babyak MA, Craighead WE, Davidson J, Hinderliter A, Hoffman B, et al. The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial. Depress Anxiety. 2021 Feb;38(2):124–33.
Blumenthal, James A., et al. “The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial.Depress Anxiety, vol. 38, no. 2, Feb. 2021, pp. 124–33. Pubmed, doi:10.1002/da.23088.
Blumenthal JA, Babyak MA, Craighead WE, Davidson J, Hinderliter A, Hoffman B, Doraiswamy PM, Sherwood A. The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial. Depress Anxiety. 2021 Feb;38(2):124–133.
Journal cover image

Published In

Depress Anxiety

DOI

EISSN

1520-6394

Publication Date

February 2021

Volume

38

Issue

2

Start / End Page

124 / 133

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sertraline
  • Psychiatry
  • Humans
  • Exercise
  • Depressive Disorder, Major
  • Depression
  • Anxiety
  • Adult
  • 5205 Social and personality psychology